# Smartbird, Inc.: financial statements, quarterly

BIRD · Nasdaq · CIK 1653909 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bird.md) · [Financials](/companies/bird/financials.md) · [Filings](/companies/bird/filings.md) · [Insiders](/companies/bird/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bird/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [57.2](/filings/0001628280-24-045882.md) | [72.0 d](/filings/0001628280-25-012130.md) | [39.3](/filings/0001653909-25-000026.md) | [51.6](/filings/0001653909-25-000051.md) | [43.0](/filings/0001628280-25-050327.md) | [55.9 d](/filings/0001628280-26-022192.md) | [32.1](/filings/0001628280-26-035302.md) | [0.0](/filings/0001437749-26-028446.md) | [33.0](/filings/0001628280-25-050327.md) | [47.7 d](/filings/0001628280-26-022192.md) | [22.3](/filings/0001628280-26-035302.md) | [2.8](/filings/0001437749-26-028446.md) |
| Cost of revenue | $m | [32.4](/filings/0001628280-24-045882.md) | [44.6 d](/filings/0001628280-25-012130.md) | [20.9](/filings/0001653909-25-000026.md) | [25.5](/filings/0001653909-25-000051.md) | [23.9](/filings/0001628280-25-050327.md) | [38.4 d](/filings/0001628280-26-022192.md) | [17.7](/filings/0001628280-26-035302.md) | [0.0](/filings/0001437749-26-028446.md) | [18.7](/filings/0001628280-25-050327.md) | [29.9 d](/filings/0001628280-26-022192.md) | [16.1](/filings/0001628280-26-035302.md) | [2.8](/filings/0001437749-26-028446.md) |
| Gross profit | $m | [24.9](/filings/0001628280-24-045882.md) | [27.4 d](/filings/0001628280-25-012130.md) | [18.5](/filings/0001653909-25-000026.md) | [26.1](/filings/0001653909-25-000051.md) | [19.1](/filings/0001628280-25-050327.md) | [17.5 d](/filings/0001628280-26-022192.md) | [14.4](/filings/0001628280-26-035302.md) | [16.2](/filings/0001653909-25-000051.md) | [14.2](/filings/0001628280-25-050327.md) | [17.8 d](/filings/0001628280-26-022192.md) | [6.2](/filings/0001628280-26-035302.md) | not reported |
| Selling, general and administrative | $m | [43.5](/filings/0001628280-24-045882.md) | [41.5 d](/filings/0001628280-25-012130.md) | [39.7](/filings/0001653909-25-000026.md) | [33.6](/filings/0001653909-25-000051.md) | [31.0](/filings/0001628280-25-050327.md) | [29.2 d](/filings/0001628280-26-022192.md) | [25.2](/filings/0001628280-26-035302.md) | [5.1](/filings/0001437749-26-028446.md) | [21.7](/filings/0001628280-25-050327.md) | [21.4 d](/filings/0001628280-26-022192.md) | [18.8](/filings/0001628280-26-035302.md) | [10.7](/filings/0001437749-26-028446.md) |
| Operating income | $m | [(30.1)](/filings/0001628280-24-045882.md) | [(57.6) d](/filings/0001628280-25-012130.md) | [(29.8)](/filings/0001653909-25-000026.md) | [(20.2)](/filings/0001653909-25-000051.md) | [(21.8)](/filings/0001628280-25-050327.md) | [(25.8) d](/filings/0001628280-26-022192.md) | [(22.8)](/filings/0001628280-26-035302.md) | [(5.1)](/filings/0001437749-26-028446.md) | [(19.9)](/filings/0001628280-25-050327.md) | [(20.7) d](/filings/0001628280-26-022192.md) | [(22.0)](/filings/0001628280-26-035302.md) | [(10.7)](/filings/0001437749-26-028446.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001437749-26-028446.md) | not reported | not reported | not reported | [1.5](/filings/0001437749-26-028446.md) |
| Income tax | $m | [0.1](/filings/0001628280-24-045882.md) | [(0.3) d](/filings/0001628280-25-012130.md) | [0.2](/filings/0001653909-25-000026.md) | [0.6](/filings/0001653909-25-000051.md) | [0.1](/filings/0001628280-25-050327.md) | [1.0 d](/filings/0001628280-26-022192.md) | [0.1](/filings/0001628280-26-035302.md) | [0.1](/filings/0001437749-26-028446.md) | [0.1](/filings/0001628280-25-050327.md) | [0.2 d](/filings/0001628280-26-022192.md) | [0.1](/filings/0001628280-26-035302.md) | [(0.0)](/filings/0001437749-26-028446.md) |
| Net income | $m | [(31.6)](/filings/0001628280-24-045882.md) | [(56.8) d](/filings/0001628280-25-012130.md) | [(27.3)](/filings/0001653909-25-000026.md) | [(19.1)](/filings/0001653909-25-000051.md) | [(21.2)](/filings/0001628280-25-050327.md) | [(25.7) d](/filings/0001628280-26-022192.md) | [(21.9)](/filings/0001628280-26-035302.md) | [(15.5)](/filings/0001437749-26-028446.md) | [(20.3)](/filings/0001628280-25-050327.md) | [(19.6) d](/filings/0001628280-26-022192.md) | [(20.7)](/filings/0001628280-26-035302.md) | [(16.4)](/filings/0001437749-26-028446.md) |
| Diluted EPS | $ per share | [(4.15)](/filings/0001628280-24-045882.md) | not reported | [(3.52)](/filings/0001653909-25-000026.md) | [(2.45)](/filings/0001653909-25-000051.md) | [(2.68)](/filings/0001628280-25-050327.md) | not reported | [(2.73)](/filings/0001628280-26-035302.md) | [(1.92)](/filings/0001653909-25-000051.md) | [(2.49)](/filings/0001628280-25-050327.md) | not reported | [(2.37)](/filings/0001628280-26-035302.md) | not reported |
| Basic EPS | $ per share | [(4.15)](/filings/0001628280-24-045882.md) | not reported | [(3.52)](/filings/0001653909-25-000026.md) | [(2.45)](/filings/0001653909-25-000051.md) | [(2.68)](/filings/0001628280-25-050327.md) | not reported | [(2.73)](/filings/0001628280-26-035302.md) | [(1.92)](/filings/0001437749-26-028446.md) | [(2.49)](/filings/0001628280-25-050327.md) | not reported | [(2.37)](/filings/0001628280-26-035302.md) | [(1.79)](/filings/0001437749-26-028446.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [132](/filings/0001628280-24-045882.md) | [130](/filings/0001628280-25-012130.md) | [102](/filings/0001653909-25-000026.md) | [87.2](/filings/0001653909-25-000051.md) | [78.6](/filings/0001628280-25-050327.md) | [66.7](/filings/0001628280-26-022192.md) | [39.1](/filings/0001628280-26-035302.md) | [33.1](/filings/0001437749-26-028446.md) | [23.7](/filings/0001628280-25-050327.md) | [26.7](/filings/0001437749-26-028446.md) | [14.4](/filings/0001628280-26-035302.md) | [37.4](/filings/0001437749-26-028446.md) |
| Current assets | $m | [236](/filings/0001653909-23-000102.md) | [212](/filings/0001628280-25-012130.md) | [185](/filings/0001628280-24-021813.md) | [165](/filings/0001628280-24-035760.md) | [155](/filings/0001628280-24-045882.md) | [131](/filings/0001628280-26-022192.md) | [97.8](/filings/0001653909-25-000026.md) | [94.3](/filings/0001653909-25-000051.md) | [80.7](/filings/0001628280-25-050327.md) | [82.1](/filings/0001437749-26-028446.md) | [64.7](/filings/0001628280-26-035302.md) | [40.9](/filings/0001437749-26-028446.md) |
| Total assets | $m | [380](/filings/0001653909-23-000102.md) | [313](/filings/0001628280-25-012130.md) | [272](/filings/0001628280-24-021813.md) | [239](/filings/0001628280-24-035760.md) | [222](/filings/0001628280-24-045882.md) | [189](/filings/0001628280-26-022192.md) | [147](/filings/0001653909-25-000026.md) | [137](/filings/0001653909-25-000051.md) | [120](/filings/0001628280-25-050327.md) | [109](/filings/0001437749-26-028446.md) | [84.7](/filings/0001628280-26-035302.md) | [46.1](/filings/0001437749-26-028446.md) |
| Current liabilities | $m | [51.2](/filings/0001653909-23-000102.md) | [48.6](/filings/0001628280-25-012130.md) | [46.7](/filings/0001628280-24-021813.md) | [40.3](/filings/0001628280-24-035760.md) | [45.9](/filings/0001628280-24-045882.md) | [44.4](/filings/0001628280-26-022192.md) | [30.4](/filings/0001653909-25-000026.md) | [36.9](/filings/0001653909-25-000051.md) | [34.1](/filings/0001628280-25-050327.md) | [40.6](/filings/0001437749-26-028446.md) | [40.8](/filings/0001628280-26-035302.md) | [11.1](/filings/0001437749-26-028446.md) |
| Total liabilities | $m | [144](/filings/0001653909-23-000102.md) | [127](/filings/0001628280-25-012130.md) | [112](/filings/0001628280-24-021813.md) | [95.5](/filings/0001628280-24-035760.md) | [94.6](/filings/0001628280-24-045882.md) | [87.2](/filings/0001628280-26-022192.md) | [64.4](/filings/0001653909-25-000026.md) | [65.5](/filings/0001653909-25-000051.md) | [68.0](/filings/0001628280-25-050327.md) | [73.5](/filings/0001437749-26-028446.md) | [68.5](/filings/0001628280-26-035302.md) | [23.6](/filings/0001437749-26-028446.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001628280-26-022192.md) | not reported | [5.0](/filings/0001653909-25-000051.md) | [12.3](/filings/0001628280-25-050327.md) | [17.4](/filings/0001628280-26-035302.md) | [17.4](/filings/0001628280-26-035302.md) | not reported |
| Shareholders' equity | $m | [236](/filings/0001628280-24-045882.md) | [185](/filings/0001628280-26-022192.md) | [160](/filings/0001653909-25-000051.md) | [144](/filings/0001628280-25-050327.md) | [127](/filings/0001628280-25-050327.md) | [102](/filings/0001437749-26-028446.md) | [82.8](/filings/0001437749-26-028446.md) | [71.4](/filings/0001437749-26-028446.md) | [51.9](/filings/0001628280-25-050327.md) | [35.9](/filings/0001437749-26-028446.md) | [16.3](/filings/0001437749-26-028446.md) | [22.5](/filings/0001437749-26-028446.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(5.4) d](/filings/0001628280-24-045882.md) | [(4.7) d](/filings/0001628280-25-012130.md) | [(26.2)](/filings/0001653909-25-000026.md) | [(15.6) d](/filings/0001653909-25-000051.md) | [(11.2) d](/filings/0001628280-25-050327.md) | [(10.8) d](/filings/0001628280-26-022192.md) | [(27.9)](/filings/0001628280-26-035302.md) | [(8.7) d](/filings/0001653909-25-000051.md) | [(15.2) d](/filings/0001628280-25-050327.md) | [(3.3) d](/filings/0001628280-26-022192.md) | [(12.1)](/filings/0001628280-26-035302.md) | [4.8 d](/filings/0001437749-26-028446.md) |
| Capital expenditure | $m | [2.1 d](/filings/0001628280-24-045882.md) | [1.2 d](/filings/0001628280-25-012130.md) | [1.1](/filings/0001653909-25-000026.md) | [1.3 d](/filings/0001653909-25-000051.md) | [0.7 d](/filings/0001628280-25-050327.md) | [1.0 d](/filings/0001628280-26-022192.md) | [0.6](/filings/0001628280-26-035302.md) | [0.7 d](/filings/0001437749-26-028446.md) | [0.9 d](/filings/0001628280-25-050327.md) | [0.9 d](/filings/0001628280-26-022192.md) | [0.1](/filings/0001628280-26-035302.md) | [2.7 d](/filings/0001437749-26-028446.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities, us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [149](/filings/0001653909-23-000087.md) | [149](/filings/0001653909-23-000102.md) | [150](/filings/0001628280-24-021813.md) | [151](/filings/0001628280-24-035760.md) | [7.6](/filings/0001628280-24-045882.md) | [7.8](/filings/0001653909-25-000026.md) | [7.8](/filings/0001653909-25-000051.md) | [7.9](/filings/0001628280-25-050327.md) | [8.0](/filings/0001628280-26-035302.md) | [8.1](/filings/0001653909-25-000051.md) | [8.2](/filings/0001628280-25-050327.md) | [8.7](/filings/0001628280-26-035302.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.